Huntington Potter
Concepts (349)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 39 | 2024 | 436 | 6.850 |
Why?
| Amyloid beta-Peptides | 22 | 2022 | 189 | 3.780 |
Why?
| Electroporation | 7 | 2018 | 31 | 2.720 |
Why?
| Transfection | 9 | 2018 | 870 | 2.410 |
Why?
| Cognition Disorders | 13 | 2012 | 476 | 2.160 |
Why?
| Amyloid beta-Protein Precursor | 14 | 2022 | 54 | 1.670 |
Why?
| Cognitive Dysfunction | 6 | 2020 | 273 | 1.560 |
Why?
| Down Syndrome | 8 | 2024 | 338 | 1.510 |
Why?
| tau Proteins | 4 | 2019 | 68 | 1.330 |
Why?
| Aneuploidy | 4 | 2017 | 85 | 1.270 |
Why?
| Neuropsychological Tests | 14 | 2020 | 913 | 1.260 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 4 | 2023 | 140 | 1.250 |
Why?
| Cognition | 11 | 2022 | 981 | 1.230 |
Why?
| Chromosome Segregation | 3 | 2013 | 36 | 1.040 |
Why?
| Mice, Transgenic | 19 | 2018 | 1953 | 0.970 |
Why?
| Neurons | 6 | 2017 | 1282 | 0.960 |
Why?
| Apolipoprotein E4 | 3 | 2022 | 32 | 0.920 |
Why?
| West Nile Fever | 2 | 2023 | 50 | 0.880 |
Why?
| Dementia | 6 | 2012 | 186 | 0.860 |
Why?
| Apolipoproteins E | 7 | 2019 | 80 | 0.860 |
Why?
| Spindle Apparatus | 3 | 2013 | 87 | 0.830 |
Why?
| Immune System | 2 | 2022 | 173 | 0.820 |
Why?
| Brain | 14 | 2024 | 2372 | 0.810 |
Why?
| Exosomes | 2 | 2020 | 91 | 0.800 |
Why?
| Peptide Fragments | 6 | 2022 | 668 | 0.750 |
Why?
| Caffeine | 4 | 2012 | 57 | 0.730 |
Why?
| Psychiatric Status Rating Scales | 5 | 2012 | 483 | 0.720 |
Why?
| Ultracentrifugation | 1 | 2020 | 48 | 0.720 |
Why?
| Hippocampus | 7 | 2022 | 696 | 0.710 |
Why?
| Apathy | 1 | 2020 | 6 | 0.710 |
Why?
| Temporal Lobe | 6 | 2012 | 79 | 0.700 |
Why?
| Animals | 37 | 2023 | 31837 | 0.700 |
Why?
| Mice | 26 | 2023 | 14935 | 0.680 |
Why?
| Presenilin-1 | 6 | 2016 | 27 | 0.660 |
Why?
| Disease Models, Animal | 15 | 2022 | 3549 | 0.640 |
Why?
| Alzheimer Vaccines | 2 | 2008 | 2 | 0.620 |
Why?
| Frontotemporal Lobar Degeneration | 1 | 2017 | 8 | 0.600 |
Why?
| Central Nervous System Stimulants | 3 | 2009 | 139 | 0.590 |
Why?
| Nanoparticles | 1 | 2020 | 313 | 0.550 |
Why?
| Amyloid | 3 | 2021 | 80 | 0.530 |
Why?
| Uniparental Disomy | 1 | 2016 | 7 | 0.530 |
Why?
| alpha 1-Antichymotrypsin | 2 | 2006 | 2 | 0.520 |
Why?
| Islet Amyloid Polypeptide | 3 | 2021 | 47 | 0.520 |
Why?
| Trisomy | 1 | 2016 | 68 | 0.500 |
Why?
| Astrocytes | 3 | 2022 | 162 | 0.500 |
Why?
| DNA | 3 | 2018 | 1351 | 0.500 |
Why?
| Atrophy | 8 | 2011 | 151 | 0.490 |
Why?
| Pneumonia, Viral | 1 | 2020 | 342 | 0.490 |
Why?
| Coronavirus Infections | 1 | 2020 | 334 | 0.490 |
Why?
| Proteomics | 1 | 2020 | 844 | 0.480 |
Why?
| Cells, Cultured | 11 | 2020 | 3897 | 0.460 |
Why?
| Receptors, Neurotransmitter | 1 | 2014 | 15 | 0.460 |
Why?
| Maze Learning | 7 | 2010 | 87 | 0.460 |
Why?
| Protoplasts | 5 | 2018 | 7 | 0.450 |
Why?
| Gene Expression | 4 | 2020 | 1422 | 0.450 |
Why?
| Nerve Growth Factors | 1 | 2014 | 71 | 0.450 |
Why?
| Mutation | 6 | 2017 | 3353 | 0.440 |
Why?
| Mitosis | 2 | 2011 | 164 | 0.440 |
Why?
| Niemann-Pick Disease, Type C | 1 | 2013 | 2 | 0.440 |
Why?
| Humans | 52 | 2024 | 114925 | 0.440 |
Why?
| Aged | 21 | 2023 | 19120 | 0.400 |
Why?
| Cholesterol, LDL | 1 | 2013 | 307 | 0.380 |
Why?
| Molecular Motor Proteins | 1 | 2011 | 33 | 0.370 |
Why?
| White Matter | 2 | 2023 | 102 | 0.360 |
Why?
| Apoptosis | 2 | 2017 | 2371 | 0.350 |
Why?
| Memory, Episodic | 2 | 2021 | 38 | 0.350 |
Why?
| Disease Progression | 6 | 2012 | 2392 | 0.350 |
Why?
| Chromosomes, Mammalian | 1 | 2009 | 26 | 0.350 |
Why?
| Receptors, LDL | 1 | 2010 | 38 | 0.340 |
Why?
| Amyloidosis | 1 | 2010 | 36 | 0.340 |
Why?
| Neuropharmacology | 1 | 2009 | 5 | 0.340 |
Why?
| Infusion Pumps, Implantable | 1 | 2009 | 20 | 0.340 |
Why?
| Plants | 4 | 2018 | 202 | 0.340 |
Why?
| Atherosclerosis | 1 | 2013 | 342 | 0.330 |
Why?
| Catheters, Indwelling | 1 | 2009 | 79 | 0.330 |
Why?
| Checklist | 1 | 2010 | 84 | 0.330 |
Why?
| Multicenter Studies as Topic | 1 | 2010 | 250 | 0.330 |
Why?
| Magnetic Resonance Imaging | 9 | 2012 | 3053 | 0.320 |
Why?
| Aged, 80 and over | 13 | 2021 | 6363 | 0.320 |
Why?
| Encephalitis | 3 | 2020 | 127 | 0.280 |
Why?
| Plasma | 1 | 2009 | 210 | 0.280 |
Why?
| Activities of Daily Living | 1 | 2009 | 350 | 0.270 |
Why?
| Herpes Zoster | 2 | 2021 | 333 | 0.270 |
Why?
| Mice, Inbred C57BL | 7 | 2017 | 4718 | 0.270 |
Why?
| Environment | 3 | 2007 | 334 | 0.260 |
Why?
| Memory | 2 | 2020 | 209 | 0.260 |
Why?
| Genetic Loci | 2 | 2019 | 263 | 0.250 |
Why?
| Dendritic Cells | 1 | 2008 | 436 | 0.250 |
Why?
| Gliosis | 2 | 2023 | 29 | 0.240 |
Why?
| Reproducibility of Results | 5 | 2010 | 2769 | 0.240 |
Why?
| Intermediate Filament Proteins | 1 | 2004 | 65 | 0.240 |
Why?
| Female | 24 | 2023 | 59571 | 0.230 |
Why?
| Genotype | 7 | 2017 | 1775 | 0.230 |
Why?
| Algorithms | 2 | 2012 | 1474 | 0.230 |
Why?
| Muscles | 2 | 2017 | 322 | 0.220 |
Why?
| Cytokines | 4 | 2022 | 1843 | 0.220 |
Why?
| Analysis of Variance | 4 | 2010 | 1227 | 0.220 |
Why?
| Cell Culture Techniques | 2 | 2018 | 344 | 0.210 |
Why?
| Predictive Value of Tests | 4 | 2011 | 1801 | 0.210 |
Why?
| Imipramine | 1 | 2022 | 12 | 0.210 |
Why?
| Genetic Predisposition to Disease | 5 | 2019 | 2102 | 0.210 |
Why?
| Cell Line | 3 | 2017 | 2640 | 0.210 |
Why?
| Plant Cells | 3 | 2010 | 7 | 0.200 |
Why?
| Polymerization | 1 | 2022 | 119 | 0.190 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2022 | 134 | 0.190 |
Why?
| Arthritis, Rheumatoid | 1 | 2010 | 1002 | 0.190 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2009 | 797 | 0.190 |
Why?
| Cerebral Cortex | 1 | 2004 | 381 | 0.190 |
Why?
| Catalysis | 1 | 2022 | 292 | 0.190 |
Why?
| Interneurons | 1 | 2022 | 96 | 0.190 |
Why?
| Arteritis | 1 | 2021 | 27 | 0.190 |
Why?
| Healthy Aging | 1 | 2021 | 17 | 0.180 |
Why?
| Male | 20 | 2021 | 55655 | 0.180 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2021 | 79 | 0.180 |
Why?
| Chemical Precipitation | 1 | 2020 | 38 | 0.180 |
Why?
| Protein Aggregation, Pathological | 1 | 2020 | 14 | 0.180 |
Why?
| Skin | 2 | 2017 | 659 | 0.170 |
Why?
| Microglia | 2 | 2023 | 202 | 0.170 |
Why?
| Case-Control Studies | 6 | 2020 | 3008 | 0.170 |
Why?
| Varicella Zoster Virus Infection | 1 | 2020 | 19 | 0.170 |
Why?
| Plaque, Amyloid | 3 | 2011 | 15 | 0.170 |
Why?
| Early Diagnosis | 2 | 2011 | 217 | 0.170 |
Why?
| Homozygote | 2 | 2017 | 188 | 0.170 |
Why?
| Herpesvirus 3, Human | 2 | 2021 | 380 | 0.170 |
Why?
| Neurites | 2 | 2023 | 43 | 0.170 |
Why?
| Gene Dosage | 2 | 2017 | 134 | 0.170 |
Why?
| Brain Mapping | 2 | 2012 | 522 | 0.150 |
Why?
| Immunity | 1 | 2019 | 121 | 0.150 |
Why?
| Epitope Mapping | 2 | 2008 | 51 | 0.150 |
Why?
| Gene Knock-In Techniques | 1 | 2018 | 46 | 0.150 |
Why?
| Thiones | 2 | 2016 | 14 | 0.150 |
Why?
| Calcium | 2 | 2014 | 1104 | 0.150 |
Why?
| Blotting, Western | 3 | 2011 | 1151 | 0.150 |
Why?
| Gene Knockout Techniques | 1 | 2018 | 99 | 0.150 |
Why?
| Phospholipase C gamma | 1 | 2017 | 26 | 0.150 |
Why?
| Glycogen Synthase Kinase 3 | 2 | 2009 | 78 | 0.140 |
Why?
| Phosphodiesterase Inhibitors | 2 | 2009 | 82 | 0.140 |
Why?
| Heterozygote | 1 | 2017 | 251 | 0.140 |
Why?
| Betacoronavirus | 1 | 2020 | 253 | 0.140 |
Why?
| Attention | 1 | 2020 | 392 | 0.140 |
Why?
| Transgenes | 1 | 2017 | 170 | 0.130 |
Why?
| Receptors, Immunologic | 1 | 2017 | 201 | 0.130 |
Why?
| Lithium Chloride | 1 | 2016 | 11 | 0.130 |
Why?
| Long-Term Potentiation | 2 | 2016 | 145 | 0.130 |
Why?
| Mammals | 2 | 2011 | 245 | 0.130 |
Why?
| Neuroimaging | 2 | 2023 | 248 | 0.130 |
Why?
| Executive Function | 1 | 2020 | 376 | 0.130 |
Why?
| Chromosomes, Human, Pair 21 | 1 | 2016 | 31 | 0.130 |
Why?
| Dendritic Spines | 1 | 2016 | 49 | 0.130 |
Why?
| Mosaicism | 1 | 2016 | 61 | 0.130 |
Why?
| Functional Laterality | 3 | 2012 | 197 | 0.130 |
Why?
| Mice, Inbred BALB C | 2 | 2008 | 1152 | 0.130 |
Why?
| Lipids | 1 | 2019 | 582 | 0.120 |
Why?
| Membrane Glycoproteins | 1 | 2017 | 429 | 0.120 |
Why?
| Biomarkers | 3 | 2022 | 3418 | 0.120 |
Why?
| Middle Aged | 10 | 2021 | 26801 | 0.120 |
Why?
| Genome-Wide Association Study | 3 | 2019 | 1197 | 0.120 |
Why?
| Polymorphism, Single Nucleotide | 3 | 2017 | 1893 | 0.120 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 369 | 0.120 |
Why?
| Pyrimidines | 2 | 2016 | 378 | 0.120 |
Why?
| Recombinant Proteins | 2 | 2023 | 1233 | 0.120 |
Why?
| PC12 Cells | 1 | 2014 | 37 | 0.120 |
Why?
| Risk Factors | 6 | 2014 | 8637 | 0.110 |
Why?
| Nerve Growth Factor | 1 | 2014 | 27 | 0.110 |
Why?
| Anxiety | 1 | 2020 | 846 | 0.110 |
Why?
| Amnesia | 2 | 2012 | 43 | 0.110 |
Why?
| Membrane Fluidity | 1 | 2013 | 10 | 0.110 |
Why?
| Immunohistochemistry | 4 | 2011 | 1635 | 0.110 |
Why?
| Pancreatitis, Alcoholic | 1 | 2012 | 2 | 0.110 |
Why?
| Cell Cycle | 1 | 2016 | 544 | 0.110 |
Why?
| Trypsinogen | 1 | 2012 | 9 | 0.110 |
Why?
| Trypsin | 1 | 2012 | 67 | 0.100 |
Why?
| Claudins | 1 | 2012 | 24 | 0.100 |
Why?
| Enzyme Inhibitors | 1 | 2016 | 752 | 0.100 |
Why?
| Memory Disorders | 2 | 2012 | 154 | 0.100 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 181 | 0.100 |
Why?
| Glutamic Acid | 1 | 2014 | 211 | 0.100 |
Why?
| Neuroglia | 1 | 2013 | 150 | 0.100 |
Why?
| Longitudinal Studies | 4 | 2012 | 2382 | 0.100 |
Why?
| Follow-Up Studies | 2 | 2011 | 4427 | 0.100 |
Why?
| Neuronal Plasticity | 1 | 2014 | 209 | 0.100 |
Why?
| Pandemics | 1 | 2020 | 1325 | 0.100 |
Why?
| Brain Chemistry | 1 | 2012 | 116 | 0.100 |
Why?
| Immunity, Innate | 1 | 2017 | 724 | 0.100 |
Why?
| Age Factors | 2 | 2009 | 2891 | 0.100 |
Why?
| Mice, Knockout | 2 | 2010 | 2586 | 0.100 |
Why?
| Centrosome | 1 | 2011 | 60 | 0.100 |
Why?
| Inflammation | 1 | 2022 | 2485 | 0.100 |
Why?
| Parkinsonian Disorders | 1 | 2011 | 27 | 0.100 |
Why?
| Entorhinal Cortex | 1 | 2011 | 9 | 0.100 |
Why?
| Myocytes, Smooth Muscle | 1 | 2013 | 236 | 0.090 |
Why?
| Molecular Targeted Therapy | 1 | 2014 | 347 | 0.090 |
Why?
| Xenopus | 1 | 2011 | 98 | 0.090 |
Why?
| Vaccines, DNA | 1 | 2010 | 30 | 0.090 |
Why?
| Oocytes | 1 | 2011 | 171 | 0.090 |
Why?
| Macrophage Colony-Stimulating Factor | 1 | 2010 | 17 | 0.090 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 2010 | 71 | 0.080 |
Why?
| Florida | 1 | 2009 | 73 | 0.080 |
Why?
| Serine Proteinase Inhibitors | 1 | 2009 | 35 | 0.080 |
Why?
| Homeostasis | 1 | 2013 | 576 | 0.080 |
Why?
| Observer Variation | 1 | 2010 | 297 | 0.080 |
Why?
| Microdialysis | 1 | 2009 | 49 | 0.080 |
Why?
| Proto-Oncogene Proteins c-raf | 1 | 2009 | 43 | 0.080 |
Why?
| Genetic Therapy | 1 | 2010 | 258 | 0.080 |
Why?
| Tubulin | 1 | 2010 | 123 | 0.080 |
Why?
| Geriatric Assessment | 1 | 2010 | 176 | 0.080 |
Why?
| Drug Synergism | 1 | 2009 | 316 | 0.080 |
Why?
| Theophylline | 1 | 2009 | 60 | 0.080 |
Why?
| Ethanol | 1 | 2013 | 548 | 0.080 |
Why?
| Psychomotor Performance | 2 | 2009 | 280 | 0.080 |
Why?
| Cell Line, Transformed | 1 | 2009 | 133 | 0.080 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2009 | 314 | 0.080 |
Why?
| Fibroblasts | 1 | 2013 | 839 | 0.080 |
Why?
| Time Factors | 2 | 2009 | 6125 | 0.080 |
Why?
| Antibody Specificity | 1 | 2008 | 176 | 0.080 |
Why?
| Drug Interactions | 1 | 2009 | 347 | 0.080 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2009 | 130 | 0.080 |
Why?
| Cross Reactions | 1 | 2008 | 117 | 0.070 |
Why?
| Cell Cycle Proteins | 1 | 2011 | 552 | 0.070 |
Why?
| Genetic Variation | 1 | 2012 | 876 | 0.070 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 929 | 0.070 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 271 | 0.070 |
Why?
| Retrospective Studies | 2 | 2022 | 12543 | 0.070 |
Why?
| Blood | 1 | 2007 | 96 | 0.070 |
Why?
| Aging | 2 | 2009 | 1621 | 0.070 |
Why?
| Exploratory Behavior | 1 | 2007 | 83 | 0.070 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2007 | 61 | 0.070 |
Why?
| Antibody Formation | 1 | 2008 | 267 | 0.070 |
Why?
| Bone Marrow | 1 | 2008 | 245 | 0.070 |
Why?
| t-Complex Genome Region | 1 | 2006 | 3 | 0.070 |
Why?
| Supranuclear Palsy, Progressive | 1 | 2006 | 5 | 0.070 |
Why?
| Drug Administration Schedule | 1 | 2009 | 718 | 0.070 |
Why?
| Up-Regulation | 1 | 2010 | 812 | 0.070 |
Why?
| Platelet-Derived Growth Factor | 1 | 2006 | 82 | 0.070 |
Why?
| Phosphorylation | 2 | 2011 | 1572 | 0.070 |
Why?
| Rolipram | 1 | 2006 | 3 | 0.070 |
Why?
| In Situ Nick-End Labeling | 1 | 2006 | 119 | 0.070 |
Why?
| Silver Staining | 1 | 2006 | 17 | 0.070 |
Why?
| Valine | 1 | 2006 | 72 | 0.070 |
Why?
| Problem Solving | 1 | 2007 | 141 | 0.070 |
Why?
| Methionine | 1 | 2006 | 144 | 0.070 |
Why?
| Superoxide Dismutase | 1 | 2007 | 305 | 0.060 |
Why?
| Behavior, Animal | 2 | 2006 | 462 | 0.060 |
Why?
| Severity of Illness Index | 2 | 2011 | 2542 | 0.060 |
Why?
| Immunologic Memory | 1 | 2008 | 313 | 0.060 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 157 | 0.060 |
Why?
| Rats | 1 | 2014 | 4963 | 0.060 |
Why?
| Microtubule-Associated Proteins | 1 | 2006 | 174 | 0.060 |
Why?
| Spinal Cord | 1 | 2007 | 348 | 0.060 |
Why?
| Spleen | 1 | 2006 | 485 | 0.060 |
Why?
| Lysine | 1 | 2006 | 242 | 0.060 |
Why?
| Flow Cytometry | 1 | 2008 | 1087 | 0.060 |
Why?
| Benzothiazoles | 1 | 2004 | 33 | 0.060 |
Why?
| Dose-Response Relationship, Drug | 1 | 2009 | 1856 | 0.060 |
Why?
| Peptides | 1 | 2009 | 848 | 0.060 |
Why?
| Genetics, Behavioral | 1 | 2004 | 43 | 0.060 |
Why?
| Thiazoles | 1 | 2004 | 110 | 0.060 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 744 | 0.060 |
Why?
| Gene Frequency | 2 | 2017 | 481 | 0.060 |
Why?
| Immunoglobulin G | 1 | 2008 | 776 | 0.060 |
Why?
| Memory, Short-Term | 1 | 2006 | 223 | 0.060 |
Why?
| Biological Specimen Banks | 1 | 2024 | 94 | 0.050 |
Why?
| Indicators and Reagents | 1 | 2003 | 99 | 0.050 |
Why?
| Diffusion Tensor Imaging | 1 | 2023 | 62 | 0.050 |
Why?
| Europe | 1 | 2024 | 336 | 0.050 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2023 | 83 | 0.050 |
Why?
| West Nile virus | 1 | 2023 | 38 | 0.050 |
Why?
| RNA, Messenger | 1 | 2010 | 2558 | 0.050 |
Why?
| Growth Disorders | 1 | 2022 | 78 | 0.050 |
Why?
| Pregnancy | 1 | 2014 | 5525 | 0.050 |
Why?
| Prognosis | 1 | 2010 | 3344 | 0.050 |
Why?
| Nuclear Proteins | 1 | 2006 | 593 | 0.050 |
Why?
| Caspase 3 | 1 | 2023 | 238 | 0.050 |
Why?
| Models, Biological | 1 | 2009 | 1630 | 0.050 |
Why?
| Viral Load | 1 | 2023 | 405 | 0.050 |
Why?
| DNA, Complementary | 1 | 2021 | 257 | 0.050 |
Why?
| Insulin-Like Growth Factor I | 1 | 2022 | 286 | 0.050 |
Why?
| T-Lymphocytes | 1 | 2008 | 1749 | 0.040 |
Why?
| Intracellular Space | 1 | 2020 | 68 | 0.040 |
Why?
| Protein Aggregates | 1 | 2020 | 65 | 0.040 |
Why?
| Extracellular Space | 1 | 2020 | 117 | 0.040 |
Why?
| Acyclovir | 1 | 2020 | 100 | 0.040 |
Why?
| Viral Envelope Proteins | 1 | 2020 | 73 | 0.040 |
Why?
| Child, Preschool | 1 | 2013 | 9083 | 0.040 |
Why?
| Adult | 3 | 2020 | 30604 | 0.040 |
Why?
| Cross-Sectional Studies | 1 | 2009 | 4406 | 0.040 |
Why?
| DNA, Viral | 1 | 2021 | 350 | 0.040 |
Why?
| Surveys and Questionnaires | 1 | 2010 | 4634 | 0.040 |
Why?
| Saccharomyces cerevisiae | 1 | 2022 | 477 | 0.040 |
Why?
| Young Adult | 1 | 2013 | 10476 | 0.040 |
Why?
| Image Processing, Computer-Assisted | 2 | 2012 | 686 | 0.040 |
Why?
| Protein Interaction Maps | 1 | 2017 | 34 | 0.040 |
Why?
| Host-Pathogen Interactions | 1 | 2020 | 295 | 0.040 |
Why?
| Haplotypes | 1 | 2019 | 453 | 0.040 |
Why?
| Gene Expression Regulation | 1 | 2006 | 2324 | 0.040 |
Why?
| Linkage Disequilibrium | 1 | 2017 | 245 | 0.030 |
Why?
| Sequence Homology, Amino Acid | 1 | 2017 | 353 | 0.030 |
Why?
| Genetic Testing | 1 | 2019 | 379 | 0.030 |
Why?
| Exome | 1 | 2017 | 201 | 0.030 |
Why?
| Discriminant Analysis | 2 | 2007 | 38 | 0.030 |
Why?
| Lipid Metabolism | 1 | 2019 | 446 | 0.030 |
Why?
| Cell Proliferation | 1 | 2023 | 2199 | 0.030 |
Why?
| Long-Term Synaptic Depression | 1 | 2016 | 48 | 0.030 |
Why?
| Sweden | 1 | 2015 | 65 | 0.030 |
Why?
| Protective Factors | 1 | 2015 | 87 | 0.030 |
Why?
| Odds Ratio | 1 | 2017 | 954 | 0.030 |
Why?
| Antiviral Agents | 1 | 2020 | 647 | 0.030 |
Why?
| Child | 1 | 2013 | 18362 | 0.030 |
Why?
| In Vitro Techniques | 1 | 2016 | 1034 | 0.030 |
Why?
| Drug Discovery | 1 | 2014 | 124 | 0.030 |
Why?
| Pedigree | 1 | 2015 | 467 | 0.030 |
Why?
| Amino Acid Sequence | 1 | 2017 | 1988 | 0.030 |
Why?
| Congresses as Topic | 1 | 2014 | 198 | 0.030 |
Why?
| Age of Onset | 1 | 2014 | 448 | 0.030 |
Why?
| Stroke | 1 | 2021 | 1019 | 0.030 |
Why?
| Kinetics | 1 | 2016 | 1555 | 0.030 |
Why?
| Autopsy | 1 | 2012 | 85 | 0.030 |
Why?
| Threonine | 1 | 2011 | 40 | 0.020 |
Why?
| Immunoprecipitation | 1 | 2011 | 152 | 0.020 |
Why?
| Motor Activity | 2 | 2007 | 641 | 0.020 |
Why?
| ROC Curve | 1 | 2012 | 448 | 0.020 |
Why?
| Reference Values | 1 | 2012 | 741 | 0.020 |
Why?
| Gene Expression Profiling | 1 | 2017 | 1523 | 0.020 |
Why?
| Clinical Trials as Topic | 1 | 2014 | 934 | 0.020 |
Why?
| Statistics as Topic | 1 | 2011 | 294 | 0.020 |
Why?
| Linear Models | 1 | 2012 | 770 | 0.020 |
Why?
| Alleles | 1 | 2012 | 791 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2011 | 543 | 0.020 |
Why?
| Protein Processing, Post-Translational | 1 | 2011 | 399 | 0.020 |
Why?
| Superoxide Dismutase-1 | 1 | 2007 | 8 | 0.020 |
Why?
| Mice, Neurologic Mutants | 1 | 2007 | 19 | 0.020 |
Why?
| Sex Factors | 1 | 2012 | 1721 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 2011 | 1355 | 0.020 |
Why?
| Random Allocation | 1 | 2007 | 335 | 0.020 |
Why?
| Corticosterone | 1 | 2007 | 211 | 0.020 |
Why?
| RNA | 1 | 2012 | 810 | 0.020 |
Why?
| Fluorescent Dyes | 1 | 2007 | 300 | 0.020 |
Why?
| Social Environment | 1 | 2007 | 283 | 0.020 |
Why?
| Motor Neurons | 1 | 2007 | 212 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2007 | 1126 | 0.010 |
Why?
| Synapses | 1 | 2007 | 330 | 0.010 |
Why?
| Avoidance Learning | 1 | 2004 | 63 | 0.010 |
Why?
| Space Perception | 1 | 2004 | 63 | 0.010 |
Why?
| Factor Analysis, Statistical | 1 | 2004 | 257 | 0.010 |
Why?
| Prospective Studies | 1 | 2014 | 6218 | 0.010 |
Why?
| Data Interpretation, Statistical | 1 | 2004 | 323 | 0.010 |
Why?
| Regression Analysis | 1 | 2004 | 947 | 0.010 |
Why?
| Cardiovascular Diseases | 1 | 2012 | 1729 | 0.010 |
Why?
| United States | 1 | 2015 | 12209 | 0.010 |
Why?
|
|
Potter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) Derived automatically from this person's publications. _
Co-Authors ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People in Profiles who have published with this person. _
Similar People ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People whose addresses are nearby this person. _
|